Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 407 * | Tue, 8/6/2013, 2:00 PM - 3:50 PM | CC-516a | |
| Recent Advances in Design and Analysis of Cancer Clinical Trials — Topic Contributed Papers | |||
| Biopharmaceutical Section , Mental Health Statistics Section , Biometrics Section | |||
| Organizer(s): Jianchang Lin, Millennium: The Takeda Oncology Company | |||
| Chair(s): Guohui Liu, Millennium: The Takeda Oncology Company | |||
| 2:05 PM | Clinical Trial Designs for Biomarker Research in Oncology — Sumithra Mandrekar, Mayo Clinic | ||
| 2:25 PM | Finding the Biologically Optimal Dose with Early Efficacy Biomarkers in Phase I Cancer Clinical Trials — Rui Qin, Mayo Clinic | ||
| 2:45 PM | A Dose-Escalation Design for Combination Cancer Therapies — Jenny Zhang, Gilead Sciences | ||
| 3:05 PM | Improving Median Progression-Free Survival Methods Through Design or Analysis — Keaven Anderson, Merck Research Laboratories ; Honghong Zhou, Merck Research Laboratories | ||
| 3:25 PM | Discussant: William Rosenberger, George Mason University | ||
| 3:45 PM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.